NovoCure (NVCR) Net Margin Growth (3y) (2017 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | -388.00 |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | -1.00 |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | -315.00 |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 1,692.00 |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | - |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 2.00 |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 1,018.00 |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 399.00 |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | - |
| 10 | NovoCure | 1.90 Bn | 1.47 Bn | 135.13 Mn | 256.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 256.00 |
| Dec 31, 2025 | 1,499.00 |
| Sep 30, 2025 | -200.00 |
| Jun 30, 2025 | -823.00 |
| Mar 31, 2025 | -1,876.00 |
| Dec 31, 2024 | -2,102.00 |
| Sep 30, 2024 | -989.00 |
| Jun 30, 2024 | -1,123.00 |
| Mar 31, 2024 | -2,492.00 |
| Dec 31, 2023 | -3,861.00 |
| Sep 30, 2023 | -4,586.00 |
| Jun 30, 2023 | -4,698.00 |
| Mar 31, 2023 | -4,731.00 |
| Dec 31, 2022 | -3,334.00 |
| Sep 30, 2022 | -2,238.00 |
| Jun 30, 2022 | -1,558.00 |
| Mar 31, 2022 | 1,320.00 |
| Dec 31, 2021 | 257.00 |
| Sep 30, 2021 | 824.00 |
| Jun 30, 2021 | 1,425.00 |
| Mar 31, 2021 | 3,669.00 |
| Dec 31, 2020 | 2,381.00 |
| Sep 30, 2020 | 2,994.00 |
| Jun 30, 2020 | 5,660.00 |
| Mar 31, 2020 | 5,562.00 |
| Dec 31, 2019 | -19,021.00 |
| Sep 30, 2019 | 15,725.00 |
| Jun 30, 2019 | 22,518.00 |
| Mar 31, 2019 | 25,491.00 |
| Dec 31, 2018 | 24,348.00 |
| Sep 30, 2018 | 27,260.00 |
| Jun 30, 2018 | 42,346.00 |
| Mar 31, 2018 | 40,711.00 |
| Dec 31, 2017 | -95,091.00 |
| Sep 30, 2017 | 39,589.00 |